Salivary gland malignant neoplasms: treatment and prognosis.
A retrospective analysis of 183 patients with malignant salivary gland tumors treated between 1955 and 1978 is presented. The analysis showed that radiation therapy lowered the recurrence rates after surgery and controlled approximately one-third of the inoperable tumors. A dose-response relationship exists and the data suggest that the radiation dose should not be less than that corresponding to a CRE-value of 1950 reu (70 Gy/7 weeks). Histology, location and clinical stage are important prognostic factors.
A
A
Borthne
K
K
Kjellevold
O
O
Kaalhus
H
H
Vermund
D000293:Adolescent; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005158:Facial Paralysis / Q000209:etiology; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D010306:Parotid Gland / Q000601:surgery; D011183:Postoperative Complications / Q000453:epidemiology; D011379:Prognosis; D011832:Radiation Injuries / Q000453:epidemiology; D012189:Retrospective Studies; D012468:Salivary Gland Neoplasms / Q000150:complications / Q000473:pathology / Q000628:therapy*